Pharmacokinetics-adapted Busulfan-based myeloablative conditioning before unrelated umbilical cord blood transplantation for myeloid malignancies in children.

about

Pharmacokinetics-adapted Busulfan-based myeloablative conditioning before unrelated umbilical cord blood transplantation for myeloid malignancies in children.

Item

http://www.wikidata.org/entity/Q52613271

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Pharmacokinetics-adapted Busul ...... loid malignancies in children.

@en

Pharmacokinetics-adapted Busul ...... loid malignancies in children.

@nl

type

Item

label

Pharmacokinetics-adapted Busul ...... loid malignancies in children.

@en

Pharmacokinetics-adapted Busul ...... loid malignancies in children.

@nl

prefLabel

Pharmacokinetics-adapted Busul ...... loid malignancies in children.

@en

Pharmacokinetics-adapted Busul ...... loid malignancies in children.

@nl

P1476

Pharmacokinetics-adapted Busul ...... loid malignancies in children.

@en

P2093

Henrique Bittencourt

http://www.w3.org/2001/XMLSchema#string

Maja Krajinovic

http://www.w3.org/2001/XMLSchema#string

Marc Ansari

http://www.w3.org/2001/XMLSchema#string

Marie-France Vachon

http://www.w3.org/2001/XMLSchema#string

Michel Duval

http://www.w3.org/2001/XMLSchema#string

Pierre Teira

http://www.w3.org/2001/XMLSchema#string

Sonia Cellot

http://www.w3.org/2001/XMLSchema#string

P2860

Pharmacokinetic targeting of intravenous busulfan reduces conditioning regimen related toxicity following allogeneic hematopoietic cell transplantation for acute myelogenous leukemia.

Glutathione S-transferase A1 genetic variants reduce busulfan clearance in children undergoing hematopoietic cell transplantation.

Analysis of risk factors influencing outcome in children with myelodysplastic syndrome after unrelated cord blood transplantation.

Pharmacogenetic aspects of drug metabolizing enzymes in busulfan based conditioning prior to allogenic hematopoietic stem cell transplantation in children.

Glutathione S-transferase gene variations influence BU pharmacokinetics and outcome of hematopoietic SCT in pediatric patients.

1994 Consensus Conference on Acute GVHD Grading

Busulfan systemic exposure relative to regimen-related toxicity and acute graft-versus-host disease: defining a therapeutic window for i.v. BuCy2 in chronic myelogenous leukemia.

Improved clinical outcome of paediatric bone marrow recipients using a test dose and Bayesian pharmacokinetic individualization of busulfan dosage regimens.

Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients.

P304

e0193862

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0193862

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Joy Benadiba

P577

2018-04-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29608607

http://www.w3.org/2001/XMLSchema#string

P932

5880335

http://www.w3.org/2001/XMLSchema#string